244 related articles for article (PubMed ID: 37790801)
1. Reintroducing Fenfluramine as a Treatment for Seizures: Current Knowledge, Recommendations and Gaps in Understanding.
Dini G; Di Cara G; Ferrara P; Striano P; Verrotti A
Neuropsychiatr Dis Treat; 2023; 19():2013-2025. PubMed ID: 37790801
[TBL] [Abstract][Full Text] [Related]
2. Fenfluramine: A Review of Pharmacology, Clinical Efficacy, and Safety in Epilepsy.
Samanta D
Children (Basel); 2022 Aug; 9(8):. PubMed ID: 36010049
[TBL] [Abstract][Full Text] [Related]
3. Fenfluramine for treatment-resistant epilepsy in Dravet syndrome and other genetically mediated epilepsies.
Sullivan J; Simmons R
Drugs Today (Barc); 2021 Jul; 57(7):449-454. PubMed ID: 34268532
[TBL] [Abstract][Full Text] [Related]
4. Fenfluramine repurposing from weight loss to epilepsy: What we do and do not know.
Odi R; Invernizzi RW; Gallily T; Bialer M; Perucca E
Pharmacol Ther; 2021 Oct; 226():107866. PubMed ID: 33895186
[TBL] [Abstract][Full Text] [Related]
5. Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine.
Dini G; Tulli E; Dell'Isola GB; Mencaroni E; Di Cara G; Striano P; Verrotti A
Front Pharmacol; 2022; 13():832929. PubMed ID: 35668937
[TBL] [Abstract][Full Text] [Related]
6. Fenfluramine for the treatment of status epilepticus: use in an adult with Lennox-Gastaut syndrome and literature review.
Strzelczyk A; Becker H; Tako L; Hock S; Hattingen E; Rosenow F; Mann C
Neurol Res Pract; 2024 Feb; 6(1):10. PubMed ID: 38383582
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Fenfluramine in Epilepsy: A Systematic Review and Meta-analysis.
Tabaee Damavandi P; Fabin N; Giossi R; Matricardi S; Del Giovane C; Striano P; Meletti S; Brigo F; Trinka E; Lattanzi S
Neurol Ther; 2023 Apr; 12(2):669-686. PubMed ID: 36853503
[TBL] [Abstract][Full Text] [Related]
8. Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial.
Lagae L; Sullivan J; Knupp K; Laux L; Polster T; Nikanorova M; Devinsky O; Cross JH; Guerrini R; Talwar D; Miller I; Farfel G; Galer BS; Gammaitoni A; Mistry A; Morrison G; Lock M; Agarwal A; Lai WW; Ceulemans B;
Lancet; 2019 Dec; 394(10216):2243-2254. PubMed ID: 31862249
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological diversity amongst approved and emerging antiseizure medications for the treatment of developmental and epileptic encephalopathies.
Sills GJ
Ther Adv Neurol Disord; 2023; 16():17562864231191000. PubMed ID: 37655228
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany.
Strzelczyk A; Pringsheim M; Mayer T; Polster T; Klotz KA; Muhle H; Alber M; Trollmann R; Spors H; Kluger G; Kurlemann G; Schubert-Bast S
Epilepsia; 2021 Oct; 62(10):2518-2527. PubMed ID: 34378197
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Selective 5-HT
Silenieks LB; Carroll NK; Van Niekerk A; Van Niekerk E; Taylor C; Upton N; Higgins GA
ACS Chem Neurosci; 2019 Jul; 10(7):3284-3295. PubMed ID: 31082204
[TBL] [Abstract][Full Text] [Related]
12. Fenfluramine for the Treatment of Dravet Syndrome and Lennox-Gastaut Syndrome.
Balagura G; Cacciatore M; Grasso EA; Striano P; Verrotti A
CNS Drugs; 2020 Oct; 34(10):1001-1007. PubMed ID: 32875491
[TBL] [Abstract][Full Text] [Related]
13. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
Lattanzi S; Trinka E; Striano P; Rocchi C; Salvemini S; Silvestrini M; Brigo F
CNS Drugs; 2021 Mar; 35(3):265-281. PubMed ID: 33754312
[TBL] [Abstract][Full Text] [Related]
14. A review of fenfluramine for the treatment of Dravet syndrome patients.
Simon K; Sheckley H; Anderson CL; Liu Z; Carney PR
Curr Res Pharmacol Drug Discov; 2022; 3():100078. PubMed ID: 34988433
[TBL] [Abstract][Full Text] [Related]
15. Individualized treatment approaches: Fenfluramine, a novel antiepileptic medication for the treatment of seizures in Dravet syndrome.
Polster T
Epilepsy Behav; 2019 Feb; 91():99-102. PubMed ID: 30269941
[TBL] [Abstract][Full Text] [Related]
16. Fenfluramine as antiseizure medication for epilepsy.
Gogou M; Cross JH
Dev Med Child Neurol; 2021 Aug; 63(8):899-907. PubMed ID: 33565102
[TBL] [Abstract][Full Text] [Related]
17. Effect of fenfluramine on seizures and comorbidities in SCN8A-developmental and epileptic encephalopathy: A case series.
Aledo-Serrano Á; Cabal-Paz B; Gardella E; Gómez-Porro P; Martínez-Múgica O; Beltrán-Corbellini A; Toledano R; García-Morales I; Gil-Nagel A
Epilepsia Open; 2022 Sep; 7(3):525-531. PubMed ID: 35802036
[TBL] [Abstract][Full Text] [Related]
18. A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication.
Strzelczyk A; Schubert-Bast S
CNS Drugs; 2022 Mar; 36(3):217-237. PubMed ID: 35156171
[TBL] [Abstract][Full Text] [Related]
19. The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
Gil-Nagel A; Falip M; Sánchez-Carpintero R; Abad-Sazatornil MR; Poveda JL; Aibar JÁ; Cardenal-Muñoz E; Aras LM; Sánchez R; Sancho-López A; Trillo-Mata JL; Torrejón M; Gil A
Epilepsy Behav; 2022 Jul; 132():108711. PubMed ID: 35588562
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: A real-world study.
Specchio N; Pietrafusa N; Doccini V; Trivisano M; Darra F; Ragona F; Cossu A; Spolverato S; Battaglia D; Quintiliani M; Luigia Gambardella M; Rosati A; Mei D; Granata T; Dalla Bernardina B; Vigevano F; Guerrini R
Epilepsia; 2020 Nov; 61(11):2405-2414. PubMed ID: 32945537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
